This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Full Agenda
Registration and Morning Coffee
Opening Remarks From The Organizer and Chair
From Next Best Action to Next Best Content With AI
David Schofield
Join David Schofield as he delves into the transformative power of auditable AI in the pharmaceutical sector, highlighting its critical role in ensuring transparency, accountability, and compliance. The talk will navigate the shift from traditional 'next best action' to 'next best content', emphasizing personalized, data-driven strategies that cater uniquely to healthcare professionals and patients. Through real-world case studies and an exploration of future AI trends, learn how these innovations are not only enhancing content delivery but also setting new standards in industry practices and decision-making processes.
David Schofield
CEO & Co-Founder
Fluence World
Empathy – A Skill at the Heart of the Bayer CX Transformation Program
Florian Gäng
This talk is for you if you are involved in transforming your organization towards more customer-centricity.
Florian will share learnings and good practices from equipping Bayer with methods and systems for experience-led growth.
While HCPs and patients become increasingly harder to reach, engage with and satisfy, many brand organizations are challenged to develop new approaches and master new skills faster than ever.
In his talk Florian will discuss why empathy is at the core of this skillset and how the Bayer VoC program, Design Principles and Experience Journey approach apply empathy to co-create customer- and business value.
- Learnings from Bayer`s CX Transformation
- The Bayer CX Measurement Program
- CX Transformation = People Transformation
Florian Gäng
Director, CX & Service Design
Bayer
Coffee-Break
Panel Discussion: Exploring the Synergy Between High-Quality Content, Data, and AI in Omnichannel Marketing
Nataliya Andreychuk
Discover the transformative impact the intersection of content, data, and AI can have on engaging and empowering HCPs.
Learn how to leverage and integrate these elements to deliver personalized customer experiences, enhance brand loyalty, and ultimately elevate HCP engagement.
Join the panel discussion for an insightful exploration of cutting-edge techniques and strategies that promise to redefine the standards of effective omnichannel communication.
Nataliya Andreychuk
Co-Founder & CEO
Viseven
Go To Market Approaches in Rare Diseases: The Role of Omni - Channel Marketing
Adil Khan
Rare disease solutions represent a growing percentage of pharmaceutical innovation. The unmet need for these patients is significant but the challenge lies in finding these patients and bringing life-saving drugs to them. But how to do this when large field forces are not affordable?
Omni–channel marketing not only provides an alternative path but rather the first-line approach toward Go To Market.
Adil Khan
Global Head of Dermatology Marketing
Boehringer Ingelheim
How To Measure Omnichannel Marketing ROI
Spencer Wilcox
Consumer Goods has long used Marketing Mix Modelling (MMM) to measure ROI of different channels and campaigns. A disruptive new approach has made it cost-effective for pharma to use MMM to measure ROI by channel, HCP specialty, visit frequency, etc.
Spencer Wilcox
Founder
Everybody Eats
Roundtable Discussion
All delegates will have 30 minutes to discuss
trending topics in the Pharma Omnichannel field.
Lunch
Omnichannel Engagement Track: The HCP Portal as the Center of the Experience
Martin Møller
Learn how Novo Nordisk aligned the organization strategically around HCP Portal, how they evolve their HCP Portal and positions it at the center of the experience for HCP Engagement.
The presentation will also touch upon how global brands deliver content and experiences for affiliates for localization and activation.
How data capture plays a role and guides both Global Brands on what content that works, what to create next, as well as guide affiliates to deliver a more personalized experience for HCPs.
Martin Møller
Global Director, Digital Engagement Strategy, Engagement Analytics & CX
Novo Nordisk
The Importance of Integrated Customer Engagement Plan
Francesco Michienzi
For pharma, improving the customer experience across stakeholders including patients, caregivers, healthcare providers (HCP) and payers can benefit both the healthcare ecosystem and the business outcome.
- What we have observed into the market during Covid period
- How the companies have reacted to emergency
- The new challenges and market evolution
- The role of multichannel and the need of orchestration
- How to measure results with new KPIs
- The Key of success
Francesco Michienzi
Global Business Operations Strategy Director, Pharma, and President of Relife
Menarini Group
Coffee-Break
Sponsored Speaking Slot
From "push to pull": Leveraging Digital and Precision Analytics to Engage HCPs More Effectively Across the CX Lifecycle
Christian Wöckel
- Holistic digital transformation strategy for marketing and sales: it's about more than just technology
- Linking business strategy with AI and new technology in commercial: insights into concrete use-cases
- Accompanying the change: Activating a network of change evangelists
- Insights and outlook
Christian Wöckel
Head of RSV Franchise Vaccines Germany
Sanofi
Customer Centricity: From Marketing and Sales to Customers
Jorge Pérez
Differentiation in Pharma is becoming increasingly more complexed. Traditional ways of working are changing and digitalization is gaining relevance as a key player in commercial strategies. However, many structures keep the same and there is not a clear consensus on how this evolution will look like in the future.
This new environment is pushing us towards rethinking our commercial approaches by understanding HCPs beyond what we already know, getting Marketing & Sales teams working around what really moves our Customers while providing value by every single interaction, maximizing all know-how with the help of digitalization and the use of new technologies.
We are living a crucial moment in our industry that will define the success of tomorrow: the ones who are able to make this evolution a fact and get it embedded in their commercial approaches and DNA will ensure a significantly competitive advantage.
- HCPs beyond Pharma's traditional Customer Segmentation
- Understanding Customer's True Needs
- Marketing & Sales, just One Voice around our Customers
- Getting the most of our people working on the field
- New commercial approaches for maximizing Customer Engagement
Jorge Pérez
Marketing Director
Daiichi-Sankyo
The Journey, Not the Destination: Digital Transformation in Pharma
Morgwn Shaw
Pharmaceutical is a culturally unique industry with regards to how we solve problems. The idea that 'there is no silver bullet' doesn't apply because making silver bullets is our business model. So when we face non Commercial, Customer, Digital and non-clinical challenges, does the culture and mindset of being 'solution builders' impact our ability to make, let alone see, the paths we must take to evolve into modern businesses?
In this presentation I hope to identify and explore some examples of how and where Pharma needs to change to truly embrace the opportunities and challenges of the world as it is today, and will be in future.
Morgwn Shaw
Associate Director, Omnichannel Strategy, Germany Bristol Myers Squibb
Coffee-Break
How to Leverage AI and Your HCP 360 Degree Data to Enhance the HCP Journey
Estelle Dierckx
In the pharmaceutical sector, extensive amount of data around healthcare professionals are collected through various channels (i.e. face-to-face, events, emails, websites, webinars & other engagement data).
The upcoming sessions will center around sharing our UCB journey, emphasizing the integration of AI to optimize the creation of a more tailored and personalized experience for healthcare professionals.
The discussions will look into key success factors and potential pitfalls, drawing insights from our own experiences. Additionally, we will provide insights into the types of AI projects that have proven instrumental in advancing our efforts towards HCP personalization.
Estelle Dierckx
Head of IT Commercial EU & International Markets
UCB
Crack the Code on Omnichannel Execution
Philip Vyt
Omnichannel is a big topic in our industry, but today it seems that we get stuck in defining what it is, conversations on the latest tech and where we should go.
Thie focus on Strategy, Capability, Process and people is relevant, but we seem to forget that ‘execution’ is one of the biggest hurdles today in every BioPharma. That struggle to execute already happens at a very basic Multichannel level, let alone orchestrating an Omnichannel model.
This panel can bring forward interesting ideas, honest reflections and learnings from the field.
Executing Omnichannel is a key challenge for many organisations, they risk to get stuck in co-creating strategies, building capabilities and wainting for the perfect integration. Well, the best moment to start executing is yesterday, the next best moment is now.
- Why do we struggle with Omnichannel execution
- What is an execution capability
- How do you start executing: stories and learnings
- Scaling execution, is that even possible?
Moderator:
Philip Vyt
Founder
Shyfit
Panelists:
Rick Hollis
Customer and Business Excellence Director
Ipsen
Stammen Alexander
International Brand Director Inflammation RA
Alfasigma
Philippe Kirby
Global Head of Channel Engagement & Execution
MSD
Registration and Morning Coffee
Opening Remarks From The Chair
Implementing Omnichannel HCP Engagement Strategies Across Global Markets
Maria Nieves Alvarado
Share insights on how to successfully implement omnichannel HCP engagement strategies across various international markets, ensuring consistency and effectiveness.
- Setting the foundation with a comprehensive strategy
- Driving cultural change from the top-down
- Achieving alignment across divisions
- Ensure localization of content for market relevance
- Foster cross-functional collaboration for success
Maria Nieves Alvarado
Associate Director, Omnichannel Marketing Excellence
Astellas
The Path to Personalization in an Always-on World
Philippe Kirby
In an always-on world what are the capabilities and tactics that Pharma must put into play to effectively engage their customers and to personalize their interactions?
- Personalization starts with the 1st engagement
- The importance of 1st party data in enabling personalization
- Ecosystem thinking to drive a seamless experience
- Technology yes, but also people and process
Philippe Kirby
Global Head of Channel Engagement & Execution
MSD
Sponsored Speaking Slot
Coffee Break
Learning of an Alchemist: Forging Gold From Lead in HCP Engagement Through Cross-Departmental Synergies. A Local Perspective.
Rodolphe Janssens
Our journey of digital transformation within a biotech affiliate is somewhat akin to the work of an alchemist. It confronts the challenge of moving away from traditional practices towards a more innovative and efficient model. We aim to transform these 'lead' elements, like our entrenched practices and divergent priorities, into 'gold', thereby enhancing our competitiveness.
This presentation will share insights and reflections on fostering effective collaboration across departments, countries, and within the global/local framework. We will focus on the practical elements of transformation: how we can accelerate the transition, increase adoption of new capabilities, and emphasize that the true north of these changes are where it should always be: customer-centric.
° Setting the scene: a midsize market
° Product-centricity, customer-centricity and competitiveness
° Alchemy in action
° Translating with flexibility the global model
° Accelerators at local level
° From lead to gold: did the chemisty work?
Rodolphe Janssens
Director Commercial Operations
Gilead Sciences
The New Pharmaceutical Commercial Model: How to Balance "Boots on the Ground" And The New Digital Tools?
Mathieu Gilbert
Why is it so difficult to evolve our commercial model in the pharmaceutical industry? What are the barriers to change that are slowing down our efforts? Despite years of discussions, investments and effort, our industry has still not been able to crack the code of a more integrated commercial model, where technology and people really bring out the best in each. Have we really been trying to profoundly change our organizations? Have we just been adding extra layers and systems? How can we really and deeply transform our mindset to unlock the potential of having different channels tailored to all of our customers.
A perspective from affiliate and from HQ.
1) Why so resistant to change?
2) Going back to basics - resisting the "shiny new toy" syndrome, or process over system.
3) Lets break barriers between functions - really
Mathieu Gilbert
EX Vice President Strategic Projects
Novo Nordisk
How to Get Your Field Team Excited About Omnichannel Plan
Rick Hollis
Just imagine! Your field teams are excited and engaged in your omnichannel plans. They were once the forgotten powerhouse of pharma promotion. But now, they rise again to become the engine of customer insights and personalisation that will truly be the difference between success and bland blah blah blah messages of same old same old.
In this session we will explore ways to engage, excite and involve your field teams in the implementation and delivery of the brand customer engagement plan. We will discuss why it is field insights that will make the difference, to help the entire brand team to personalize the communications to specific customers that really resonate.
- Why field teams are integral to success - Who do you think you are talking to?
- What do they need? Collaboration
- Hero events and touch point journeys
- Insights = personalisation
- Close the loop & leave them satisfied
Rick Hollis
Customer and Business Excellence Director
Ipsen
Lunch
Digital Analytics: Enabling Teams to Understand and not be Threatened by AI Technology in Customer Engagement.
Sergio Cortes Abad
In today's rapidly evolving digital landscape, the integration of AI technology has become inevitable. However, the fear of AI replacing human roles often looms large, hindering its seamless adoption. This talk willunravel this complexity and shed light on strategies to enable teams not only to understand but to embrace AI's potential without apprehension.
Through this discussion, we will explore practical approaches and transformative insights aimed at fostering a harmonious collaboration between human intelligence and AI capabilities. Join this talk on this journey to discover how teams can leverage AI as an invaluable tool rather than view it as a threat in revolutionizing customer engagement experiences.
- Understanding AI's Role: Importance of educating teams about AI's role in customer engagement, highlighting its augmentative nature rather than a replacement for human capabilities.
-Fostering Collaboration: Encouraging collaboration between AI systems and human teams would be a key focus, stressing the synergy that arises when both work in tandem to enhance customer experiences.
-Building Trust and Confidence: The talk underscored strategies to build trust and confidence among teams regarding AI, illustrating how transparency and open communication are vital in this process.
-Continuous Learning and Adaptation: Continuous learning and adaptation, emphasizing that teams should evolve alongside AI technology to leverage its full potential in customer engagement.
Sergio Cortes
Corporate Director Digital Business, Operational Excellence & Customer Experience
Ferrer
Building Organizational Digital Fluency to Reshape Pharma Customer Engagement
Hugo Barbosa
As an industry our life before COVID-19 was easier! Our entire commercial model was based on the number of F2F calls we needed in order to maximize the value of each customer. But then... Suddenly, we saw ourselves in a situation where we could not engage physically with our customers and this brought digital to be a top priority.
In that sense, a new hybrid engagement model, that evolved during this period, blends both in-person and digital engagements!
Now, while no one knows exactly how the right blend looks like... one think seems to be clear: a trend for a personalized approach taking into account each individual customer, his digital and scientific profile, his preferences, his activity etc
However, personalization is a complex task, it takes deep knowledge of the customer, and perfect visibility to his entire experience.
It is such an amount of information that can´t simply be managed by a person or a team.
Because it has implications not only in technology but also in ways of working, Metrics, Leadership, Culture and Capabilities, successful omnichannel engagement, at scale, requires a certain level of Digital Fluency.
Bullet Points:
- Introduction
- Digital Fluency Concept
- Digital Fluency Dimensions
Digital Foundations
Digital operations
Digital leadership Culture
Workforce technology quotient
- Where are we as an industry
- Where to Focus Moving Forward
Hugo Barbosa
EU Customer Omnichannel Director
ViiV Healthcare
Coffee Break
Reimagining Healthcare: Harnessing the Power of Generative AI and Data Insights
Daniel Viriato
Specific examples on how pharma industry is embedding Gen AI and data insights to improve decision making processes, efficiencies and strategies, and how can we further use these tools to improve healthcare systems and patient outcomes.
Daniel Viriato
Head of Oncology
Novartis
Panel Discussion: Master Pre & Early-Launch KOL Engagement Through Channel & Content Excellence
Claude Waddington
The pharmaceutical landscape is rapidly transforming, and it has become increasingly crucial for companies to adopt omnichannel marketing strategies while fostering early relationships with KOLs and DOLs. This expert panel discussion aims to delve into current industry trends, share effective strategies, and uncover ground-breaking solutions that can help you optimize omnichannel marketing efforts and cultivate influential KOL alliances to boost your pharmaceutical launches and market presence.
Panel Discussion Format:
The panel discussion will feature a moderator introducing the topic and guiding the conversation among panellists. Each panellist will share their expertise and experiences, followed by a Q&A session where attendees can ask questions and engage with the experts.
Key Talking Points:
- KOL Journey Mapping: How to identify critical touchpoints and create seamless, personalized experiences across channels
- Channel Integration and Consistency: Strategies for ensuring a unified brand presence and messaging across all platforms
- Data-Driven Personalization: Leveraging AI and analytics to tailor content and drive engagement
- KOL Identification and Engagement: Building meaningful relationships with influencers to enhance credibility and reach
- Content Strategy and Co-Creation: Developing valuable, engaging content in collaboration with KOLs
- Compliance and Regulatory Considerations: Navigating the complex landscape while executing impactful campaigns
- Performance Metrics and Measurement: Tracking success, optimizing strategies, and ensuring continuous improvement
Moderator:
Claude Waddington
MD & Principal Consultant Commercial Strategy
The Palindromic
Panelists
Hugo Barbosa
EU Customer Omnichannel Director
Viiv Healthcare
Christian Wöckel
Head of RSV Franchise @Vaccines Germany
Sanofi
Prasant Vijayakumar
Head of Content Strategy and Enablement
Viseven
Final Roundtable
Closing Coffee Break
Bus/Boat Sightseeing - Hippo Trip
Join us on a fun amphibious tour of Lisbon.
Pickup - Sana Metropolitan Hotel
Drop-off - Sana Metropolitan Hotel
Lunch